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Summary The antiproliferative effects of gossypol on human MCF-7 mammary cancer cells and cyclin Dl-transfected HT-1060 human
fibrosarcoma cells were investigated by cell cycle analysis and effects on the cell cycle regulatory proteins Rb and cyclin Dl. Flow cytometry
of MCF-7 cells at 24 h indicated that 10 gm gossypol inhibited DNA synthesis by producing a G,/S block. Western blot analysis using anti-
human Rb antibodies and anti-human cyclin Dl antibodies in MCF-7 cells and high- and low-expression cyclin Dl-transfected fibrosarcoma
cells indicated that, after 6 h exposure, gossypol decreased the expression levels of these proteins in a dose-dependent manner. Gossypol
also decreased the ratio of phosphorylated to unphosphorylated Rb protein in human mammary cancer and fibrosarcoma cell lines. Gossypol
(10gM) treated also decreased cyclin D1-associated kinase activity on histone Hi used as a substrate in MCF-7 cells. These results suggest
that gossypol might suppress growth by modulating the expression of cell cycle regulatory proteins Rb and cyclin Dl and the phosphorylation
of Rb protein.
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Gossypol, a polyphenolic compound extracted from cotton seeds,
has long been recognized as an anti-fertility agent and, more
recently, it has been demonstrated to inhibit the growth of various
carcinoma cell lines in vitro (Floridi et al, 1983; Joseph et al, 1983;
Haspel et al, 1984; Tuszynski and Cossu, 1984; Band et al, 1989;
Benz et al, 1990; Jaroszewski et al, 1990) and in vivo (Wu et al,
1989; Rao et al, 1985) including oestrogen-sensitive (MCF-7 and
MCF-7 Adr) and -insensitive (MDA-MB-231) human mammary
cancer cells (Hu et al, 1993; Gilbert et al, 1995). Clinically,
gossypol has been efficacious in the treatment ofmetastatic adrenal
cancer (Flack etal, 1993), holding promise as an anti-tumour agent.
Numerous biochemical studies have been conducted to eluci-
date the mechanisms by which gossypol exerts its antiproliferative
effects (Rosenberg et al, 1986; Adlakha et al, 1989). Data are
limited and understanding of gossypol's influence on cell cycle
control ofDNA synthesis and antimitogenic activity is incomplete
(Wang and Rao, 1984; Thomas et al, 1991). We wished to deter-
mine whether gossypol could induce changes in the expression of
cell cycle regulatory proteins, such as the retinoblastoma (Rb)
gene product (pRb) and cyclin Dl, in human mammary cancer
cells, a tumour type associated with mutation of the Rb gene (Lee
et al, 1988; T'Ang et al, 1988; Varley et al, 1989) as well as over-
expression and amplification of cyclin Dl (Buckley et al, 1993;
Keyomarsi and Pardee, 1993). In addition, we studied the influ-
ence of gossypol on the phosphorylation of Rb protein. For this
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purpose we used the human mammary cancer cell line MCF-7,
which has oestrogen and progesterone receptors, as do certain
human cancers in vivo. Additionally, we wished to study gossypol
effects on cell cycle phases in MCF-7 cells. Furthermore, to deter-
mine the importance of gossypol inhibition on cyclin DI and Rb
protein in its antiproliferative effect, we performed similar studies
in human fibrosarcoma cells that overexpress cyclin Dl.
MATERIALS AND METHODS
Cell culture
MCF-7 human mammary cancer cells and HT 1060 human
fibrosarcoma cells were obtained from the American Type Culture
Collection (Rockville, MD, USA).
The HT 1080 cells were maintained in log-phase growth in
RPMI medium (Media Preparation Core Facility, Sloan-Kettering
Institute) supplemented with 10% FCS (Sigma, St Louis, MO,
USA). Transfection ofa cyclin DI-expressing plasmid was carried
out as previously described (Hochhauser et al, 1996). Relative
expression ofcyclin Dl mRNA ratios were 14.4 and 0.48 for the
high- and low-expression clones, whereas the comparable cyclin
Dl expression ratios were 2.88 and 0.9 as compared with the
vector-only-transfected control (Hochhauser et al, 1996).
Racemic gossypol (Sigma) dissolved in dimethylsulphoxide
(DMSO) was added to culture medium samples [Dulbecco's
modified Eagle medium (DMEM) (Ham's F12/DME, 2:1, v/v)
supplemented with 10% fetal calf serum (FCS), 100 ig ml-' strep-
tomycin, 100 U ml-' penicillin and 2 mm glutamine] and incubated
at 37°C in a 5% carbon dioxide/95% air atmosphere for 24 h. In
order to minimize gossypol oxidation, reduced glutathione was
added to the culture medium (2 mM).
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[3H]Thymidine incorporation assay
MCF-7 human mammary cancer and HT 1080 human fibrosar-
coma cells were inoculated individually in six-well dishes (9.6 cm2
area) in a volume of2 ml ofDMEM supplemented with 10% FCS
at a density of 5 x 104 cells per well. After 2 days, gossypol
dissolved in DMSO was added to the culture medium. Incubations
with gossypol were carried out for various time intervals at 37°C.
Before cell harvest, cells were labelled with [3H]thymidine
(20 gCi per well) at 37°C for 3 h and washed three times with
Hanks' balanced salt solution (HBSS). Cells were solubilized
with 0.5% SDS (w/v) at 37°C for 10 min.
To cell lysates, 10% trichloroacetic acid (TCA) (v/v) was added
and incubation continued for 30 min on ice. TCA-precipitated
samples were filtered using glass fibre filters (Enzo Diagnostics,
Syosset, NY, USA) to separate bound and free radioactivity. Filters
were then washed three times with ice-cold 10% TCA (v/v).
Radioactivity retained on the filters was determined with a scintil-
lation counter. The radioactivity of each sample was normalized
by protein concentration determined by the A562 micro-
bicinchoninic acid protein assay (Pierce Chemical, Rockford, IL,
USA). All colorimetric procedures were carried out with a Gilford
model 260 spectrophotometer.
Cell cycle analysis
MCF-7 cells treated with various concentrations ofgossypol were
trypsinized. Cell suspensions were centrifuged (1000 r.p.m.,
10 min) and then washed twice with Ca2+/Mg2+-free HBSS to
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remove excess trypsin. After the final wash, cell pellets were
resuspended in 1 ml of HBSS buffer. Cells were then fixed and
permeabilized with 70% (v/v) ethanol at 4°C ovemight. Next day,
cell pellets were prepared by centrifugation at 1000 r.p.m. for 10
min. Cell pellets were resuspended in HBSS buffer containing 50
,ug ml-' propidium iodide. Incubation continued for 1 h at room
temperature. Cells were filtered through nylon mesh (41 gm)
(Spectrum, Houston, TX, USA).
DNA content was analysed on an Epics Profile Cytometer.
Propidium iodide-stained nuclei were excited with a 488-nm air-
cooled argon laser, and fluorescence emission greater than 680 nm
was recorded on a linear scale. A minimum of20 000 nuclei were
counted per sample. Doublets and clumps were excluded from the
analysis by gating on a bivariate distribution of the peak fluores-
cence signal.
Western blot analysis
After incubation for periods up to 3 days with different concentra-
tions ofgossypol, MCF-7 orcyclin DI-transfected HT 1080 human
fibrosarcoma cells were washed twice with ice-cold HBSS and then
lysed at 4°C with extraction buffer [20 mm Hepes buffer (pH 7.2),
1% Triton-X 100 (v/v), 10% glycerol (v/v), 2 mm sodium fluoride,
1 mm sodium orthovanadate, 50 jig ml-1 leupeptin and 0.5 mm
phenylmethylsulphonyl fluoride (PMSF). Cell lysates were
clarified by centrifugation at 15 000 r.p.m. at 4°C for 30min.
Supernatants containing equal amounts ofprotein in each lane were
subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE)
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Figure 1 Effect of gossypol concentration on antiproliferative action in high and low cyclin Dl-expressing fibrosarcoma cells. The incorporation of [3H]thymidine
into DNA was determined in fibrosarcoma cells after addition of gossypol (2.5-10 lM) or 95% (v/v) DMSO (final concentration < 0.2%, v/v). Results are
expressed as c.p.m. [3H]thymidine per unit (OD280) of protein and represent the means ± s.d. of triplicate wells. Data presented are representative of three
similar experiments
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Table 1 Cell cycle distribution of MCF-7 cells after gossypol treatment
Cell cycle phases (% of cells)
Gossypol (gM) GJG, S G2 Mitotic index
After24 h treatment
Control 63.3 26.9 9.8 0.579
0.1 68.8 23.4 7.7 0.452
1 69.5 23.5 7.8 0.450
2.5 71.4 20.5 8.2 0.401
5 71.2 24.3 4.5 0.404
7.5 78.2 17.8 4.8 0.289
10 78.8 16.7 5.2 0.277
After48 h oftreatment
Control 81.4 12.9 5.7 0.228
1 78.6 15.5 5.9 0.272
2.5 80.5 10.8 8.7 0.242
5 87.95 6.15 5.9 0.136
7.5 91.1 3.65 5.3 0.097
10 88.8 6.05 5.15 0.126
using a Bio-Rad miniprotein II electrophoresis apparatus (Bio-Rad
Laboratories, Richmond, CA, USA). After electrophoresis at a
constant 150 V for about 1 h, proteins in the gel were transferred to
a nitrocellulose membrane (Bio-Rad) by electroblot transfer at
100 V for 2 h at 4°C in a transfer buffer (pH 8.3) containing 20%
methanol (v/v), 150 mm glycine and 20 mm Tris, using a Bio-Rad
minitransblot electrophoretic transfer apparatus. Rainbow-coloured
protein molecular weight standards obtained from Amersham were
used for the estimation of molecular size. Membranes with trans-
ferred proteins were treated with blocking solution [1 x TBS (Tris-
buffered saline), fraction V 3% bovine serum albumin (BSA), 0.2%
Tween 20 (v/v)] for 1 h at room temperature and washed with
1 x TBS buffer for 20 min. Purified mouse anti-human Rb gene
product monoclonal antibody (Pharmingen, San Diego, CA, USA)
(1 jg ml-1), or rabbit anti-human cyclin Dl polyclonal antibody
(Upstate Biotechnology Inc, Saranac Lake, NY, USA) (1 ,ug) in
blocking solution was then added to the membranes and incubated
overnight at 4°C. Similar Western blot analyses were performed
with control proteins and their corresponding antisera, i.e. cdk4,
p21, actin and vinculin.
On the following day the nitrocellulose membranes were
washed with 1 x TBS for 20 min and incubated with horseradish
peroxidase conjugated either with anti-mouse or anti-rabbit IgG
for 1 h at room temperature. Secondary antibody was at a concen-
tration of 1:1000 dilution. Afterreaction, membranes were washed
and developed by chemiluminescence (ECL) (Amersham)
(Whitehead et al, 1979), and exposed to XAR5 film (Kodak).
The monoclonal antibody for pRB was obtained from
Pharmingen (cat. no. 14001A). Cell extracts were prepared as in
the manufacturer's instructions (Santa Cruz Biotechnology).
Protein concentrations were estimated by the Bradford assay as
described. Immunoblots were prepared as in the manufacturer's
instructions (Santa Cruz Biotechnology). Total protein (100 jg)
was loaded for each sample after addition of SDS polyacrylamide
sample buffer and boiling for 5 min. Protein loading was visual-
ized by Poinceau staining. Samples were electrophoresed on 7%
polyacrylamide/SDS gels. Nitrocellulose membranes (Optitran,
Schleicher & Schuell) were incubated with the enhanced
chemiluminescence system as described in the manufacturer's
instructions (Amersham) and exposed to film.
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Figure 2 Representative DNA histograms of (A) untreated MCF-7 cells. Cell
cycle data: % G1 = 63.3, % G2 = 9.8, % S = 26.9, G/G1 = 1.926; chi-square =
1.4. (B) MCF-7 cells treated with 10 gM gossypol after 24 h (flow cytometry).
Cell cycle data: % G1 = 78.0, % G2 = 5.2, % S = 16.7G/G1 = 1.960; chi-
square = 2.9
In vitro cyclin Dl kinase assay
MCF-7 cells (106 cells per 100 mm dish) treated with or without
10 jM gossypol for 24 h were lysed in 0.3 ml of lysis buffer
containing 50 mM Tris (pH 8.0), 120 mm sodium chloride,
50 mm sodium fluoride, 0.1 mm sodium vanadate, 2 mm EDTA,
10 jig ml- each of chymostatin, leupeptin, antipain and pepstatin
A; 2 jig ml 4-(2-aminoethyl)benzenesulphonyl fluoride and 0.4%
Nonidet P-40. The extracts were clarified by centrifugation at 14
000 r.p.m. for 15 min at 4°C. Lysates were incubated for 1.5 h at
4°C with polyclonal antibody against cyclin Dl. Immune
complexes were collected using 20 jil ofprotein A-Sepharose and
washed three times with 1 ml oflysis buffer and once with 1 ml of
kinase buffer containing 20 mM Tris (pH 7.5)-10 mm magnesium
chloride. Histone HI kinase assay was performed on a bead. The
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Figure 3 Western blot analysis of the effect of gossypol on the expression of
Rb protein in MCF-7 cells. Cells were treated with the indicated gossypol
concentrations for 24 h. Protein from cell lysates (20 tg) was loaded into
each lane for Western blot using mouse anti-human Rb monoclonal antibody
(1 9 g ml-'). Detection of Rb protein was done by the ECL method
36kDa h 0 16 20 2
h 0 2 4 6 8 12 16 20 24
Figure 5 Time course of gossypol effect on the expression of cyclin Dl in
MCF-7 cells. Cells were treated with 10gM gossypol for the indicated periods
of time. Protein (100 ,ug) from cell lysates was loaded into each lane for
Western blot analysis using rabbit anti-human cyclin Dl polyclonal antibody
(1 ,ug ml-'). Detection of cyclin Dl was done by the ECL method
C G (10gM)
histone Hi - *
-*- 36 kC Cyclin Dl -*
Gossypol (itM) 0 0 0.1 1 2.5 5.0 7.5 10
Figure 4 Western blot analysis of the effect of gossypol on the expression of
cyclin Di in MCF-7 cells. Cells were treated with the indicated gossypol
concentrations for 24 h. A 100-igg aliquot of protein from cell lysates (100 jg)
was loaded into each lane for Western blot using polyclonal rabbit anti-
human cyclin Di polyclonal antibody (1 jig ml-'). Detection of cyclin Di was
done by the ECL method
beads were mixed with 15 ,ul of a kinase reaction mix containing
2 ,ug of histone Hl and [32P]ATP. After 30 min at 30°C, 25 ,ul of
2 x SDS-PAGE buffer was added and 20 ,ul was analysed by
SDS-PAGE and autoradiography.
RESULTS
Antiproliferation
As in other systems, the antiproliferative effects of gossypol have
been established with [3H]thymidine uptake and cell stage
analyses (Wang and Rowe, 1984; Thomas et al, 1991). We
employed these techniques to validate their applicability to MCF-
7 human mammary cancer cells and HTl080 fibrosarcoma cells
transfected with cyclin Dl.
We assessed the antiproliferative effects of gossypol by
counting the number of viable MCF-7 cells (trypan blue exclu-
sion). Gossypol inhibited growth of MCF-7 human mammary
cancer cells in a dose-dependent manner with an estimated IC50 of
3 gM over a 3-day incubation period (data not shown). In addition,
the dose dependence and the kinetics of inhibition of [3H]thymi-
dine incorporation into DNA were determined. In the MCF-7 cells
the pattern ofanti-mitogenesis was dose and time related (data not
shown). Six hours after the addition of the drug, all gossypol
concentrations produced a significant decrease in thymidine
uptake, with 10 gM gossypol causing a 50% reduction in thymi-
dine incorporation. Gossypol concentrations of 7.5 and 5 JIM
attained 50% reduction in thymidine incorporation after 11 and
16 h respectively.
Figure 6 Effect of gossypol on histone Hi kinase. MCF-7 cells were treated
with or without 10gM gossypol for 24 h. Total cell lysates (50 9g) were
immunoprecipitated with polyclonal anti-human cyclin Dl antibody
conjugated with protein A-Sepharose. Immunoprecipitated samples were
assayed for histone Hi kinase activity by incubation of [32P-y]ATP with
histone Hi as detailed in Materials and methods. Protein from cell lysates
(100 9g) was loaded into each lane and was subjected to SDS-PAGE and
[32P]histone Hi identified by radioautography
From [3H]thymidine uptake, we determined the antiproliferative
effects of gossypol in both high and low cyclin DI-transfected
fibrosarcoma cells. After exposure to increasing concentrations
(2.5-10 ,UM) of gossypol for 24 h, we observed a progressive
decrease in 3H incorporation in both high and low cyclin Dl-
expressing fibrosarcoma cells with IC90 values of 8 tM and 4 gM
respectively (Figure 1).
Effects of gossypol on the cell cycle phases in MCF-7
human mammary cancer cells
We determined whether the antimitogenic effects of gossypol in
MCF-7 cells were cell cycle related. The effects of different
gossypol concentrations on cell cycle phases were studied with a
fluorescence-activated cell sorter (FACS) at 24 and 48 h (Table 1).
After 24 h, and more noticeably after 48 h, exposure to gossypol
was associated with a significant decrease in the proportion of
cells in S phase, when replication of DNA occurs (12.9% for
untreated cells as compared with 3.65% for the 7.5 gM gossypol-
treated cells). In addition, the percentage of cells in the G, pre-
mitotic stage was progressively raised with increasing gossypol
concentrations (78.8% for 10 g,M gossypol-treated cells as
compared with 63.3% for control). There was a decrease in the
proportion of cells in G2. Figure 2 shows representative DNA
histograms of MCF-7 cells in culture medium for 24 h: (a)
untreated cells; (b) 10 ,UM gossypol-treated cells. These results
support the conclusion that gossypol reduces the mitotic index
(MI = S+G2/M/G,) in MCF-7 cells by blocking cells in the G,
phase, as is evidenced by a dose-dependent increase in cell
percentages in these phases.
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Figure 7 Western blot analysis of cyclin Dl expression with varying
concentrations of gossypol (0.1-10 lM) (Figure 8A) and time (at 10 gM)
gossypol (Figure 8B) on high-expression cyclin Dl human fibrosarcoma cells
A Gossypol (rM)
0 0.1 0.5 1.0 2.5 5.0 10
Cyclin DI *.
Figure 9 Western blot of total cell extracts probed with a monoclonal
antibody for pRb. Samples were electrophoresed on a 7%
polyacrylamide/SDS gel. The upper and lower arrows denote phosphorylated
and underphosphorylated pRb respectively. Lane 1, HT1080 cells
transfected with neo; lane 2, HT1080 cells expressing cyclin D1; lane 3, HT
1080 cells; lane 4, HT1080 cells expressing cyclin Dl exposed to 7.5 gM
gossypol. Lane 1, HT1080 cells expressing low levels of cyclin D1; lane 2,
HT1080 cells expressing low levels of cyclin Dl exposed to 7.5 1M gossypol;
lane 3, HT1080 cells expressing high levels of cyclin D; lane 4, HT1080 cells
expressing high levels of cyclin D exposed to 7.5 gM gossypol
B Gossypol (10gM)
0 2 4 6 8 h
CyclinDl
Figure 8 Western blot analysis of Rb protein expression with varying
concentrations of gossypol (0.1-10 gM) (Figure 9A) and time (at 10 gM)
(Figure 9B) on low-expression cyclin Dl human fibrosarcoma cells
Effects of gossypol on cell cycle related proteins
MCF-7 human mammary cancercells
As pRb is an important cell cycle protein governing transition
from GI to S phase we investigated whether the activity of
gossypol could be mediated through expression of tumour-
suppressor genes. We determined whether the expression of pRb
was changed following exposure to gossypol. Western blot
analysis using mouse anti-human Rb monoclonal antibody demon-
strated that, after 24 h, gossypol decreased expression levels ofRb
protein in MCF-7 cells in a dose-dependent manner (Figure 3).
This suggests that gossypol might act, in part, by decreasing Rb
protein in MCF-7 cells. The kinetics of the gossypol effect on Rb
protein expression indicate that 10 gM gossypol decreased Rb
protein levels as early as 8 h and almost completely at 16 h (data
not shown). Western blot analysis of MCF-7 cell lysates treated
with gossypol revealed only a single band in control and lower
concentrations (1 and 2 gM) of gossypol. At concentrations of
5 gM and higher a second, more rapidly migrating, band appeared
with disappearance of the more slowly migrating band (Figure 3).
This is consistent with the slower moving band representing
phosphorylated Rb protein and the more rapidly moving band
being non-phosphorylated Rb.
Whereas the growth-suppressing activity of Rb is regulated by
its phosphorylation state, which in turn is regulated by cyclin
D1/Cdk4 complexes in other mammalian cells, it was ofinterest to
determine whether gossypol also affects the expression of these
proteins in MCF-7 cells. We have found that gossypol also
decreased cyclin Dl protein levels in MCF-7 cells in a dose-
dependent manner (Figure 4). The effect of 10 JM gossypol on
cyclin Dl was apparent as early as 6 h and almost completely at
16 h (Figure 5). Gossypol (10 JM) decreased cyclin DI-associated
kinase activity on histone Hi as a substrate in MCF-7 cells after
24 h of treatment (Figure 6). Although gossypol at the highest
concentration tested (10 JM) produced a 50% antiproliferative
effect, gossypol (10 JM) over 24 h had no effect on expression of
Cdk4, actin, vinculin or p21 (data not shown). Thus, the effects on
cyclin D, Rb and histone Hl kinase would appear not to be an
experimental artifact due to cell loss.
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HT 1080 cyclin Dl overexpressing human fibrosarcoma
cells
In view ofthe effects ofgossypol on cyclin Dl expression in MCF-
7 cells, it was of interest to determine the influence ofgossypol in
cells expressing high levels of cyclin DI. Incubation of high-
expression cyclin Dl human fibrosarcoma cells with gossypol led
to a decrease in cyclin Dl expression with half-maximal responses
between 2.5 and 5 ,UM (at 24 h) and approximately 12 h (at 10gM)
(Figure 7A and 7B). With low-expression cyclin Dl human
fibrosarcoma cells, there was a decrease in cyclin DI expression
with half-maximal responses at approximately 2 gM (at 24 h) and
approximately 4 h (at 10gM) (Figure 8A and B).
To investigate whether overexpression of cyclin Dl would
modulate the antiproliferative effect of gossypol, we exposed
HT1080 cells transfected with cyclin Dl to drug. These cells
express increased amounts of cyclin Dl and show an increase in
the number of cells in S and G2 phases. There is consequently an
increased proportion of phosphorylated pRb in cells over-
expressing cyclin Dl on immunoblotting. The HT1080 cell line
expressing the neo vector only and a transfectant with high levels
of cyclin Dl were exposed to varying doses of gossypol (Figure
1). The results indicated an IC50 of4gM and 8 gM respectively.
Immunoblotting of HT1080 cells expressing the neo vector and
a transfectant expressing high levels of cyclin Dl was carried out
(Figure 9). As previously noted, there is an increase in the propor-
tion of phosphorylated pRb in the cell line expressing high levels
of cyclin Dl. Exposure to gossypol reduced expression ofpRb in
both cell lines. However, even after exposure to 7.5 gM gossypol,
pRb was exclusively in the unphosphorylated state in the neo-
expressing cells, whereas phosphorylated pRb was detectable in
the clone expressing high levels of cyclin Dl. This suggests that
resistance to gossypol-induced growth arrest in the line expressing
high levels of cyclin Dl may be due to the increase in the propor-
tion ofphosphorylated pRb in this line compared with the parental
cell line.
DISCUSSION
Numerous biochemical effects of gossypol have been described,
such as uncoupling of oxidative phosphorylation and inhibition of
many membrane-associated enzymes (Lee et al, 1982; Bugeja et
al, 1988; Nakamura et al, 1988). Indeed, in our earlier studies of
the effects of gossypol on human erythrocyte function, we noted
that 10gM gossypol inhibited inorganic anion exchange and inter-
action with band 3 without effect on eight other membrane func-
tions (Haspel et al, 1985). However, it has been difficult to
determine the specific site and mechanism of action or link these
actions to the tumoricidal effects ofgossypol in vitro.
To elucidate other molecular mechanisms that could mediate
gossypol's antiproliferative effects (data not shown), we first
assessed the overall effect of gossypol on the cell cycle of MCF-7
cells. Our data on cell cycle analysis in non-synchronized popula-
tions ofMCF-7 cells suggest that gossypol arrests cells in G1/S, in
agreement with other studies demonstrating that gossypol inhibits
growth in vitro by reducing the growth fraction (Wang and Rao,
1984; Thomas et al, 1991). As gossypol specifically acts in theGI
phase to prevent cells from entering S phase, it was of interest to
determine whether gossypol could affect cell cycle-regulated
proteins, in particular Rb and cyclin Dl proteins, which are critical
for G. to S progression. Rb protein is known to be crucially
involved in cellular growth regulation and exists as hypo- and
hyperphosphorylated forms, its phosphorylation status being
highly cell cycle phase dependent (Cooper & Whyte, 1989). The
unphosphorylated form ofthe Rb protein is found in quiescent and
GI phase cells, restricting G, to S progression by an interaction
with the E2F transcription factor (Chellappan et al, 1991). It is a
target of complex formation with several oncoproteins, e.g. E7,
known to have an immortalizing effect on infected cells (Green,
1989), an inactivation mechanism functionally similar to the Rb
protein phosphorylation or to its loss by gene mutation or deletion,
resulting in unregulated cell proliferation. Introduction of the Rb
gene into cancer cells lacking a functional endogenous Rb gene
has been found to reverse their transformed phenotype and tumori-
genicity, a finding providing conclusive evidence of its tumour-
suppressing activity (Huang et al, 1988).
We found that the expression levels ofthe Rb and pRb proteins
decreased in response to gossypol treatment in MCF-7 cells, a
cancer cell line that predominantly expresses the phosphorylated
form of the Rb protein (Lee et al, 1988). In SDS-PAGE gels in
which non-phosphorylated was separated fromphosphorylated Rb
protein, we noted a greater decrease in the more slowly migrating
pRb band. This is consistent with a decrease in phosphorylated Rb
due to inhibition ofphosphorylation. There may also be inhibition
of Rb protein expression after gossypol treatment (Figure 3).
Whether gossypol affects Rb protein expression at the transcrip-
tional and/or translational as well as post-translational level
remains to be determined.
We have also demonstrated that gossypol decreases the expres-
sion ofcyclin DI protein in MCF-7 cells. Cyclin DI is considered
to be essential for progression through the G, phase of the cell
cycle in a variety ofhuman normal and tumour cells (Baldin et al,
1993; Lukas et al, 1994). It has been shown that cyclin Dl associ-
ates with Cdk4 during theGI phase in synchronized cells (Kato et
al, 1993). The cyclin D1-Cdk4 complex assembled in a subcel-
lular assay or as a result ofthe coexpression ofcyclin DI and Cdk4
in intact insect cells phosphorylates the Rb protein in vitro
(Matsushime et al, 1992; Kato et al, 1993). It has been suggested,
therefore, that cyclin DI functions by inactivating the inhibitory
effects of the Rb protein on cell cycle progression (Jiang et al,
1993). Gossypol treatment did not affect Cdk4 levels but inhibited
cyclin DI expression. This may account for the observed reduction
in cyclin DI-associated kinase activity on histone HI in MCF-7
cells (Figure 6). Gossypol, through its ability to decrease the
concentration ofcyclin DI may effectively decrease the amount of
phosphorylated Rb and, thus, arrest cells in GI. The correspon-
dence of the gossypol effects on both Rb and cyclin D1 as
reflected in similar kinetics (Figure 5) and concentration (Figures
3 and 4) is consistent with cyclic Dl in association with Cdk4
catalysing the phosphorylation of Rb. The effects of gossypol on
other cyclins and Cdks required for entry into S phase, such as
cyclin E, Cdk2 and Cdk5, remain to be studied. To confirm the
role of cyclin DI in mediating the effect of gossypol, we exposed
HT1080 cells transfected with cyclin DI to gossypol. These cells
have been demonstrated to have increased phosphorylation of
pRb. Gossypol has a lesser effect on proliferation in transfectants
with high cyclin Dl. Furthermore, although these cells also
show a reduction in pRb expression after exposure to gossypol,
phosphorylated pRb is detectable in cells with high cyclin Dl.
Recently, small protein inhibitors of cyclin-Cdk (Ckis) have
been shown to play an important role in regulating the activity of
cyclin-dependent kinases. In mammals, pI6, p21 and p27 have
been shown to inhibit cyclin D1-Cdk4 (Toyoshima and Hunter,
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1994). In a preliminary study, we investigated whether gossypol-
inducedGI arrest could be mediated by changes in the expression
of p21, a protein known to interact with several cyclin-Cdks in
vivo (Harper et al, 1993). Although p21 levels did not change after
gossypol treatment (data not shown), the effects of gossypol on
other Ckis remain to be determined.
Our in vitro assays support, but do not prove, an association
between the cell cycle-modulating activity of gossypol and its
antiproliferative effects. There is a similar course ofgossypol inhi-
bition ofthymidine incorporation into DNA as ofgossypol inhibi-
tion of cyclin Dl and Rb protein expression and phosphorylation
in MCF-7 cells.
If the in vitro changes observed in the expression of Rb and
cyclin Dl proteins account for the antiproliferative properties of
gossypol, this may prove conceptually and therapeutically impor-
tant through cell cycle regulation (reregulation). In addition,
whether the observed changes in cyclin Dl protein expression and
Rb protein expression and phosphorylation represent the essential
feature associated with both the anti-tumour and contraceptive
properties ofgossypol remain to be established.
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ABBREVIATIONS
BSA, bovine serum albumin; Cdk, cyclin-dependent kinase; Cki,
cyclin-dependent kinase inhibitory protein; DMEM, Dulbecco's
modified Eagle medium; DMSO, dimethylsulphoxide; ECL,
enhanced chemiluminescence; FACS, fluorescence-activated cell
sorter; FCS, fetal calf serum; HBSS, Hanks' balanced salt solu-
tion; PMSF, phenylmethylsulphonyl fluoride; Rb, retinoblastoma;
SDS-PAGE, sodium dodecyl sulphate polyacrylamide gel electro-
phoresis; TBS, Tris-buffered saline; TCA, trichloroacetic acid.
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